60 likes | 76 Views
Global viral clearance service market is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026.
E N D
Viral Clearance Service Market Application - Recombinant Proteins, Tissue and Blood Derived Products, Vaccines; Method - Viral Removal, Viral Inactivation (Chemical, Radiation); End user - Biopharmaceuticals, Contract Research Organizations, Academic Research InstitutesForecast From 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved
Viral Clearance Service Market: Snapshot Increase in demand for detection of virus removal/inactivation in products during their early stages of development. Rising prevalence of diseases, such as cardiovascular, diabetes, and oncological, robust pipeline of pharmaceutical and biopharmaceutical products, increasing expenditure on research and development tin viral clearance service provider companies are major factors driving the global viral clearance service market. Viral clearance service market has been segmented based on application, method, end-user, and region. ©2019 Transparency Market Research, All Rights Reserved
Reports Highlights • Global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026. • Major players - • Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXiAppTec, Clean Cells, and Vironova Biosafety. Request Sample ©2019 Transparency Market Research, All Rights Reserved
To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U